The all-day empty calorie feast that happens each year around the Super Bowl can be a challenge for anyone concerned about his or her waist, hips and thighs.
A blood test used on sample tissues to detect early stage pancreatic cancer is showing encouraging results and one day may lead to improved detection and treatment of the disease in ...
NEW YORK (Reuters Health) - Older men considering robotic surgery for prostate cancer shouldn't trust the rosy ads promoting the expensive technology over low-tech surgery.
NEW YORK (Reuters Health) - Older Icelandic men who remember chugging a lot of milk in their teens are three times as likely to be diagnosed with advanced prostate cancer as ...
NEW YORK (Reuters Health) - In a new study of middle-aged New Jersey men, taking cholesterol-lowering drugs was linked to a lower chance of dying from prostate cancer.
NEW YORK (Reuters Health) - For men with aggressive prostate cancer, hormone-targeted therapy cuts the overall risk of death, according to a new review of past studies.
Impacted1 Lives
By
Lynette Summerill
HERWriter
on November 30, 2011 - 8:29pm
(Reuters) - Medicare and Medicaid will cover the cost of infusion associated with Dendreon Corp's prostate cancer vaccine Provenge, the company said on Monday.